
RABIFINE PLUS CAP
Rabeprazole 20 mg & Itopride 150 mg Capsules
Product Specification
| Composition | Rabeprazole 20 mg & Itopride 150 mg Capsules |
|---|---|
| Dosage form | Capsule |
| Specification | In-house |
| Therapeutic category | Gastrointestinal & Hepatic |
| Shelf life | 24 months |
| Pack | Alu-Alu 10X10 |
| Dossier | CTD / eCTD / ACTD dossier compilation provided on request |
| Registrations | Available on request |
Manufacturing & Quality:
Produced on WHO-GMP oral solid dosage manufacturing lines. Accreditations applicable to this line: WHO-GMP. Data integrity is maintained to 21 CFR Part 11, with electronic records and batch documentation logged, access-controlled and audit-ready.



